Document is current
Any future updates will be listed below
-
Authors
Fraysse, Jeremy
Priest, Julie
Turner, Matthew
Hill, Steffan
Jones, Bryn
Verdier, Gustavo
Letang, Emilio
-
Funding
Funding for this research was provided by:
ViiV Healthcare
- License Information
-
More Information
Article History
Received: 5 November 2024
Accepted: 16 December 2024
First Online: 18 January 2025
Declarations
:
: Jeremy Fraysse, Julie Priest, Bryn Jones, and Emilio Letang are employees of ViiV Healthcare and own stock in GSK. Matthew Turner and Steffan Hill are employees of HEOR Ltd, which received funding from ViiV Healthcare to support this analysis. Gustavo Verdier is an employee of ViiV Healthcare.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
